Safety and how the body processes GH001 inhalation in healthy people
This early-stage study tests a new inhaled medication called GH001 in healthy volunteers to understand how it's absorbed into the body and check for side effects. Researchers want to make sure it's safe before testing it in people with medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good overall physical and mental health
- Your BMI (height-to-weight ratio) is between 18.5 and 35
- Your lung function is normal, with no asthma or breathing problems
- You have not taken any experimental medications in the past 90 days
- You are not allergic to mebufotenin, bufotenin, melatonin, or triptan drugs
- You are not currently enrolled in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new inhaled drug (GH001) moves through the body of healthy volunteers. It uses a special device to deliver the drug and checks how much gets into your blood.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.
This is an early-stage safety study testing a new inhaled medication called TRL1068 in people without lung disease. Researchers want to make sure the drug is safe and well-tolerated when breathed in.
Hear when a new Healthy Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.